Insider Buying Activity: Carey Dorman Acquires NOMD Shares

Carey Dorman, an insider at NOMD, recently purchased 22,654 shares of the company on June 22, 2026. This transaction was not part of a pre-planned trading program and reflects Dorman's direct investment in the company. The shares were acquired at an unspecified price, while the stock traded around $10.65 on Thursday.

Other Institutional Activity in NOMD

Several institutional investors have been adjusting their positions in NOMD. Brown Advisory Inc reduced its holdings by 480,656 shares, leaving it with 6,517,712 shares valued at about $62.6 million, a 6.9% decrease. Allspring Global Investments Holdings, LLC also trimmed its position by 164,211 shares to hold 5,454,596 shares worth approximately $52.2 million, a 2.9% decrease. Boston Partners made a significant reduction, selling 3,811,484 shares, resulting in a 43.2% decrease, leaving them with 5,009,106 shares valued at $48.1 million. In contrast, River Road Asset Management, LLC increased its holdings by 174,955 shares to 3,817,484 shares valued at $36.7 million, a 4.8% increase. Massachusetts Financial Services Co /MA/ boosted its stake by 723,005 shares, a 26% increase, ending with 3,502,661 shares worth about $33.8 million.

Insider Buying and Selling at Nomad Foods Limited

In addition to Carey Dorman, several other insiders made purchases on June 22, 2026. Parry Victoria, Melanie Dawn Stack, James Lillie, and Amit Pilowsky each bought shares ranging from 13,972 to 21,856. Earlier, on May 15, 2026, Dominic Brisby, NOMD's CEO, purchased 150,000 shares at an average price of $9.79.

Analysts Set New Price Targets

Analysts have provided various ratings and targets for NOMD. On April 15, 2026, Barclays maintained a 'buy' rating with a $12 price target. Deutsche Bank downgraded the stock to 'hold' with a $10 target on March 30, 2026. Mizuho has consistently maintained a 'buy' rating, with price targets of $13 and $15 in recent months.

Bottom Line

Carey Dorman's recent purchase of NOMD shares suggests confidence in the company's prospects. While several institutional investors have reduced their stakes, others have increased their positions, reflecting mixed sentiment. Analyst opinions also vary, with some maintaining 'buy' ratings and others taking a more cautious approach. Investors often track insider and institutional activity for insights, but it's important to remember that these activities are backward-looking and may not reflect current views.